English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/61426
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorMoreno, Beatriz-
dc.contributor.authorEspejo, Carmen-
dc.contributor.authorMestre, Leyre-
dc.contributor.authorSuardíaz, Margarita-
dc.contributor.authorClemente, Diego-
dc.contributor.authorCastro Soubriet, Fernando de-
dc.contributor.authorFernández-Fernández, Óscar-
dc.contributor.authorMontalbán, Xavier-
dc.contributor.authorVilloslada, Pablo-
dc.contributor.authorGuaza, Carmen-
dc.date.accessioned2012-11-28T12:29:46Z-
dc.date.available2012-11-28T12:29:46Z-
dc.date.issued2012-
dc.identifier.citationRevista de Neurologia 54: 114-124 (2012)-
dc.identifier.issn0210-0010-
dc.identifier.urihttp://hdl.handle.net/10261/61426-
dc.description.abstractIntroduction. The advance in the achievement of efective therapies for multiple sclerosis (MS), the defnition of appropriate therapeutic windows and to establish better diagnostic and prognostic biomarkers have become a challenging task for both researchers and clinicians. Some pitfalls in clinical trials might be related to lack of adequacy of the preclinical studies in MS experimental animal models. Aim. To standardize the methodological protocols of experimental models by developing a set of guidelines for preclinical studies by groups of experts from REEM (Spanish Network for MS). Development. A guide with recommendations for the application of MS models including a detailed assessment of appropriate experimental models taking into account the objective of the study that has been presented. Standards and quality criteria necessary in a preclinical study have been included. Conclusions. Standardized animal models of MS are essential to increase the success of the preclinical fndings in order to transfer them to the clinical practice. © 2012 Revista de Neurología.-
dc.language.isospa-
dc.publisherViguera Editores-
dc.rightsopenAccess-
dc.titleGuidelines on the appropriate use of animal models for developing therapies in multiple sclerosis-
dc.title.alternativeGuía de uso adecuado de modelos animals para el desarrollo de terapias en esclerosis múltiple-
dc.typeartículo-
dc.identifier.doi10.33588/rn.5402.2011424-
dc.relation.publisherversionhttp://doi.org/10.33588/rn.5402.2011424-
dc.date.updated2012-11-28T12:29:46Z-
dc.description.versionPeer Reviewed-
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
Guaza,2012,RevNeurol,54.pdf191,82 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.